← Leaderboards
Toshiyasu Taniguchi
Fred Hutchinson Cancer Research Center
$2,984,026
Attributed
$3,663,622
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $811.4K · FY2007–16$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$3,663,622 · 4
By mechanism
R01$1,571,963 · 1
P50$1,359,193 · 1
R21$732,466 · 2
Top collaborators
- Elizabeth Mary Swisher5 shared
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- Adam P. Geballe$12,800,633
- David Mark Hockenbery$14,036,112
- Morgan B Hakki$592,650
- Silvia Balbo$4,806,163
Others in their field
Top investigators on “Resistance”
- Judith S. Currier · University Of California Los Angeles$243,611,225
- Gregory H Reaman · National Childhood Cancer Foundation$217,720,574
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$180,092,958
- Ralph Parchment · Leidos Biomedical Research, Inc.$149,556,948
- Wafaa M. El-Sadr · Columbia University Health Sciences$113,991,858
- Peter C Adamson · National Childhood Cancer Foundation$113,790,601
Research focus
ResistanceCellsMalignant NeoplasmsDna RepairBaseBrca2 GeneLeadCancer-Predisposing GeneBrca1 GeneMalignant Neoplasm Of OvaryCancer CellBreastMutationPlayResponseCisplatinBrca2 MutationMutateProtein ExpressionBrca1 MutationClinically RelevantGerm-Line MutationChemotherapyIn Vitro
Grant awards (13)
The DGCR8-mediated UV response pathway$264,000
R21 · FY2016 · ES · contact PI
Clinical Implication of the Acquisition of BRCA1/2 Function in BRCA1/2-Deflcient$262,827
P50 · FY2013 · CA · contact PI
Clinical Implication of the Acquisition of BRCA1/2 Function in BRCA1/2-Deflcient$280,661
P50 · FY2012 · CA · contact PI
The Fanconi Anemia-BRCA Pathway And Chemosensitivity of Human Cancer$310,947
R01 · FY2011 · CA · contact PI
Clinical Implication of the Acquisition of BRCA1/2 Function in BRCA1/2-Deflcient$257,007
P50 · FY2011 · CA · contact PI
The Fanconi Anemia-BRCA Pathway And Chemosensitivity of Human Cancer$320,565
R01 · FY2010 · CA · contact PI
Clinical Implication of the Acquisition of BRCA1/2 Function in BRCA1/2-Deflcient$273,694
P50 · FY2010 · CA · contact PI
The Fanconi Anemia-BRCA Pathway And Chemosensitivity of Human Cancer$314,279
R01 · FY2009 · CA · contact PI
Clinical Implication of the Acquisition of BRCA1/2 Function in BRCA1/2-Deflcient$285,004
P50 · FY2009 · CA · contact PI
MicroRNAs Regulating The Fanconi Anemia-BRCA Pathway$212,118
R21 · FY2009 · HL · contact PI
The Fanconi Anemia-BRCA Pathway And Chemosensitivity of Human Cancer$308,883
R01 · FY2008 · CA · contact PI
MicroRNAs Regulating The Fanconi Anemia-BRCA Pathway$256,348
R21 · FY2008 · HL · contact PI
The Fanconi Anemia-BRCA Pathway And Chemosensitivity of Human Cancer$317,289
R01 · FY2007 · CA · contact PI